
|Articles|March 20, 2016
Escalating Drug Costs Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Higher Ultra-Processed Food Intake Linked to Increased Prediabetes Risk in Young Adults
3
Pharmacist Spotlight: Amir Masood, PharmD
4
Ziftomenib Receives FDA Approval for Acute Myeloid Leukemia With NPM1 Mutations
5


















































































































































































































